Evofem Biosciences, Inc. filed its 10-K on Apr 27, 2023 for the period ending Dec 31, 2022. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.014 USD | +2.94% | +0.72% | -78.12% |
1st Jan change | Capi. | |
---|---|---|
-78.12% | 844K | |
+30.03% | 684B | |
+30.34% | 568B | |
-3.92% | 361B | |
+18.03% | 329B | |
+4.27% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.01% | 166B |
- Stock Market
- Equities
- EVFM Stock
- News Evofem Biosciences, Inc.
- Evofem Biosciences, Inc. Auditor Raises 'Going Concern' Doubt